Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
14-(4-(2,6-Dimethoxy-4-(2-methyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)benzyl)piperazin-1-yl)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-3,6,9,12-tetraoxatetradecanamide
ID: ALA5283301
Max Phase: Preclinical
Molecular Formula: C47H58N8O12
Molecular Weight: 927.02
This compound is available for customization.
Associated Items: